Spine Biologics Market Size, Share & Trends Analysis Report By Product (Bone Graft Substitutes, Spinal Allografts, Cell-based Matrix), By End Use (Hospitals, ASCs), And Segment Forecasts, 2019 - 2026

Published: Sep, 2019 | Pages: 120 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global spine biologics market size is expected to reach USD 2.5 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.2% CAGR over the forecast period. The market is primarily driven by increasing incidence of spinal injuries. Prevalence of spinal deformities has been on a rise in developed and underdeveloped countries and this has resulted in an increase in the number of surgeries being carried. This has had a positive impact on the market for spine biologics.

Apart from this, growing awareness about numerous advantages of biologics in spine fusion surgeries, such as minimal postoperative time and ability to activate cellular growth, has also propelled the market. Biomaterials and bone graft substitutes are being adopted as the choice of treatment for spinal deformities. Increasing percentage of the elderly population suffering from spinal disorders and rising adoption of these products as a treatment method is anticipated to boost the market for spine biologics over the forecast period.

The geriatric population is more prone to spondylolisthesis and degeneration of disc. This, coupled with increasing number of trauma cases due to road accidents and sports injuries, is driving demand for spine biologics. According to the Open Access Journal for Minimally Invasive Surgery (MIS) published in 2018, minimally invasive techniques are being adopted for the treatment of a wide range of spine pathologies. Approximately 400,000 cases are performed in the U.S. annually and spine fusion has turned out to be one of the most commonly performed and well-established treatment options for spine trauma, degenerative disorders, tumors, and structural abnormalities.

Further key findings from the report suggest:

• Many clinicians consider spinal allografts as the gold standard for spinal fusion. The use of biologics influences surgical outcomes as it helps in improving fusion rates and reducing pain. This driven the segment to account for the dominant revenue share

• Hospitals held the leading share in terms of end use in 2018 owing to availability of highly skilled professionals and increasing number of spine surgeries performed. Ambulatory Surgery Centers (ASC), on the other hand, are anticipated to witness lucrative growth over the forecast period

• North America captured the largest share in the market in 2018, owing to presence of well-established healthcare infrastructure, high awareness among surgeons pertinent to bone graft procedures, and availability of favorable reimbursement policies

• Asia Pacific is anticipated to show significant growth through 2026. Booming medical tourism industry offering advanced healthcare services at affordable costs is the key factor driving the regional spine biologics market

• Some of the key companies are Stryker; Orthofix International N.V.; K2M Inc.; Exactech Inc.; Wright Medical Technology Inc.; DePuy Synthes Companies; Zimmer Holding Inc.; Nuvasive Inc.; and Medtronic Inc. Strategic acquisitions and presence of new entrants are making the market immensely competitive.

 Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Product
                        1.1.2. End use
                        1.1.3. Regional scope
                        1.1.4. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR's internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                        1.6.2. Volume price analysis (Model 2)
                            1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1: Understanding the market dynamics
                        1.9.2. Objective 2: Understanding the market estimates and forecasts
                        1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
                        1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Spine Biologics Market Variables, Trends & Scope
                    3.1. Market Lineage outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Product Pipeline Analysis
                    3.4. Market Dynamics
                        3.4.1. Market Driver Analysis
                            3.4.1.1. Growing prevalence of spine deformities
                            3.4.1.2. Growing technological advancements in spine biologics
                            3.4.1.3. Growing geriatric population
                        3.4.2. Market Restraint Analysis
                            3.4.2.1. The significant cost of bone grafts
                            3.4.2.2. Unfavorable reimbursement policies
                        3.4.3. Industry Challenges
                    3.5. Spine Biologics: Market Analysis Tools
                        3.5.1. Industry Analysis - Porter's
                            3.5.1.1. Supplier Power
                            3.5.1.2. Buyer Power
                            3.5.1.3. Substitution Threat
                            3.5.1.4. Threat from new entrant
                            3.5.1.5. Competitive rivalry
                        3.5.2. PESTEL Analysis
                            3.5.2.1. Political Landscape
                            3.5.2.2. Environmental Landscape
                            3.5.2.3. Social Landscape
                            3.5.2.4. Technology Landscape
                            3.5.2.5. Legal Landscape
                        3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Spine Biologics Market: Segment Analysis, By Product, 2014 - 2026 (USD Million)
                    4.1. Definitions & Scope
                    4.2. Product market share analysis, 2018 & 2026
                    4.3. Segment Dashboard
                    4.4. Global Spine Biologics Market, by Product, 2014 to 2026
                    4.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following
                        4.5.1. Spinal Allografts
                            4.5.1.1. Machined Bones Allograft
                            4.5.1.2. Demineralized Bone Matrix
                        4.5.2. Bone Graft Substitutes
                            4.5.2.1. Bone Morphogenetic Proteins
                            4.5.2.2. Synthetic Bone Grafts
                        4.5.3. Cell-based Matrix
Chapter 5. Spine Biologics Market: Segment Analysis, By End-use, 2014 - 2026 (USD Million)
                    5.1. Definitions & Scope
                    5.2. End-use market share analysis, 2018 & 2026
                    5.3. Segment Dashboard
                    5.4. Global Spine Biologics Market, by End-use, 2014 to 2026
                    5.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following
                        5.5.1. Hospitals
                        5.5.2. Ambulatory Care Centers
                        5.5.3. Others
Chapter 6. Spine Biologics Market: Regional Market Analysis, By Region, 2014 - 2026 (USD Million)
                    6.1. Definitions & Scope
                    6.2. Regional Market Share Analysis, 2018 & 2026
                    6.3. Regional Market Dashboard
                    6.4. Regional Market Snapshot
                    6.5. Regional Market Share, 2018
                    6.6. Market Size, & Forecasts, and Trend Analysis, 2014 to 2026:
                    6.7. North America
                        6.7.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                        6.7.2. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                        6.7.3. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.7.4. U.S.
                            6.7.4.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.7.4.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.7.5. Canada
                            6.7.5.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.7.5.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                    6.8. Europe
                        6.8.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                        6.8.2. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                        6.8.3. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.8.4. U.K.
                            6.8.4.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.8.4.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.8.5. Germany
                            6.8.5.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.8.5.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.8.6. France
                            6.8.6.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.8.6.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.8.7. Italy
                            6.8.7.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.8.7.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.8.8. Spain
                            6.8.8.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.8.8.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.8.9. Russia
                            6.8.9.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.8.9.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                    6.9. Asia Pacific
                        6.9.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                        6.9.2. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                        6.9.3. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.9.4. Japan
                            6.9.4.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.9.4.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.9.5. China
                            6.9.5.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.9.5.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.9.6. India
                            6.9.6.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.9.6.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.9.7. Singapore
                            6.9.7.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.9.7.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.9.8. Australia
                            6.9.8.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.9.8.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.9.9. South Korea
                            6.9.9.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.9.9.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                    6.10. Latin America
                        6.10.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                        6.10.2. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                        6.10.3. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.10.4. Brazil
                            6.10.4.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.10.4.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.10.5. Mexico
                            6.10.5.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.10.5.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.10.6. Argentina
                            6.10.6.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.10.6.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                    6.11. Middle East and Africa
                        6.11.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                        6.11.2. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                        6.11.3. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.11.4. South Africa
                            6.11.4.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.11.4.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.11.5. Saudi Arabia
                            6.11.5.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.11.5.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
                        6.11.6. UAE
                            6.11.6.1. Market estimates and forecast, by product, 2014 - 2026 (USD Million)
                            6.11.6.2. Market estimates and forecast, by end-use, 2014 - 2026 (USD Million)
Chapter 7. Spine Biologics Market - Competitive Analysis
                    7.1. Key companies profiled
                        7.1.1. Stryker Corporation
                            7.1.1.1. Company Overview
                            7.1.1.2. Financial Performance
                            7.1.1.3. Product Benchmarking
                            7.1.1.4. Strategic Initiatives
                        7.1.2. Orthofix Holdings, Inc.
                            7.1.2.1. Company Overview
                            7.1.2.2. Financial Performance
                            7.1.2.3. Product Benchmarking
                            7.1.2.4. Strategic Initiatives
                        7.1.3. DePuy Synthes
                            7.1.3.1. Company Overview
                            7.1.3.2. Financial Performance
                            7.1.3.3. Product Benchmarking
                            7.1.3.4. Strategic Initiatives
                        7.1.4. Wright Medical Group N.V.
                            7.1.4.1. Company Overview
                            7.1.4.2. Financial Performance
                            7.1.4.3. Product Benchmarking
                            7.1.4.4. Strategic Initiatives
                        7.1.5. Exactech, Inc.
                            7.1.5.1. Company Overview
                            7.1.5.2. Financial Performance
                            7.1.5.3. Product Benchmarking
                            7.1.5.4. Strategic Initiatives
                        7.1.6. Zimmer Biomet
                            7.1.6.1. Company Overview
                            7.1.6.2. Financial Performance
                            7.1.6.3. Product Benchmarking
                            7.1.6.4. Strategic Initiatives
                        7.1.7. NuVasive, Inc.
                            7.1.7.1. Company Overview
                            7.1.7.2. Financial Performance
                            7.1.7.3. Product Benchmarking
                            7.1.7.4. Strategic Initiatives
                        7.1.8. Arthrex, Inc.
                            7.1.8.1. Company Overview
                            7.1.8.2. Financial Performance
                            7.1.8.3. Product Benchmarking
                            7.1.8.4. Strategic Initiatives
                        7.1.9. Medtronic
                            7.1.9.1. Company Overview
                            7.1.9.2. Financial Performance
                            7.1.9.3. Product Benchmarking
                            7.1.9.4. Strategic Initiatives
                        7.1.10. Organogenesis, Inc.
                            7.1.10.1. Company Overview
                            7.1.10.2. Financial Performance
                            7.1.10.3. Product Benchmarking
                            7.1.10.4. Strategic Initiatives
                        7.1.11. Lattice Biologics Ltd.
                            7.1.11.1. Company Overview
                            7.1.11.2. Financial Performance
                            7.1.11.3. Product Benchmarking
                            7.1.11.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Global spine biologics market, by region 2014 - 2026 (USD Million)
Table 4 Global spine biologics market, by product, 2014 - 2026 (USD Million)
Table 5 Global spine biologics market, by bone grafts spine biologics, 2014 - 2026 (USD Million)
Table 6 Global spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 7 North America spine biologics market, by country, 2014 - 2026 (USD Million)
Table 8 North America spine biologics market, by product, 2014 - 2026 (USD Million)
Table 9 North America spine allografts market by type, 2014 - 2026 (USD Million)
Table 10 North America bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 11 North America spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 12 U.S. spine biologics market, by product, 2014 - 2026 (USD Million)
Table 13 U.S. spine allografts market by type, 2014 - 2026 (USD Million)
Table 14 U.S. bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 15 U.S. spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 16 Canada spine biologics market, by product, 2014 - 2026 (USD Million)
Table 17 Canada spine allografts market by type, 2014 - 2026 (USD Million)
Table 18 Canada bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 19 Canada spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 20 Europe spine biologics market, by country, 2014 - 2026 (USD Million)
Table 21 Europe spine biologics market, by product, 2014 - 2026 (USD Million)
Table 22 Europe spine allografts market by type, 2014 - 2026 (USD Million)
Table 23 Europe bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 24 Europe spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 25 U.K. spine biologics market, by product, 2014 - 2026 (USD Million)
Table 26 U.K. spine allografts market by type, 2014 - 2026 (USD Million)
Table 27 U.K. bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 28 U.K. spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 29 Germany spine biologics market, by product, 2014 - 2026 (USD Million)
Table 30 Germany spine allografts market by type, 2014 - 2026 (USD Million)
Table 31 Germany bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 32 Germany spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 33 France spine biologics market, by product, 2014 - 2026 (USD Million)
Table 34 France spine allografts market by type, 2014 - 2026 (USD Million)
Table 35 France bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 36 France spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 37 Italy spine biologics market, by product, 2014 - 2026 (USD Million)
Table 38 Italy spine allografts market by type, 2014 - 2026 (USD Million)
Table 39 Italy bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 40 Italy spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 41 Spain spine biologics market, by product, 2014 - 2026 (USD Million)
Table 42 Spain spine allografts market by type, 2014 - 2026 (USD Million)
Table 43 Spain bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 44 Spain spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 45 Russia spine biologics market, by product, 2014 - 2026 (USD Million)
Table 46 Russia spine allografts market by type, 2014 - 2026 (USD Million)
Table 47 Russia bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 48 Russia spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 49 Asia Pacific spine biologics market, by country, 2014 - 2026 (USD Million)
Table 50 Asia Pacific spine biologics market, by product, 2014 - 2026 (USD Million)
Table 51 Asia Pacific spine allografts market by type, 2014 - 2026 (USD Million)
Table 52 Asia Pacific bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 53 Asia Pacific spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 54 Japan spine biologics market, by product, 2014 - 2026 (USD Million)
Table 55 Japan spine allografts market by type, 2014 - 2026 (USD Million)
Table 56 Japan bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 57 Japan spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 58 China spine biologics market, by product, 2014 - 2026 (USD Million)
Table 59 China spine allografts market by type, 2014 - 2026 (USD Million)
Table 60 China bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 61 China spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 62 India spine biologics market, by product, 2014 - 2026 (USD Million)
Table 63 India spine allografts market by type, 2014 - 2026 (USD Million)
Table 64 India bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 65 India spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 66 Australia spine biologics market, by product, 2014 - 2026 (USD Million)
Table 67 Australia spine allografts market by type, 2014 - 2026 (USD Million)
Table 68 Australia bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 69 Australia spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 70 Singapore spine biologics market, by product, 2014 - 2026 (USD Million)
Table 71 Singapore spine allografts market by type, 2014 - 2026 (USD Million)
Table 72 Singapore bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 73 Singapore spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 74 South Korea spine biologics market, by product, 2014 - 2026 (USD Million)
Table 75 South Korea spine allografts market by type, 2014 - 2026 (USD Million)
Table 76 South Korea bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 77 South Korea spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 78 Latin America spine biologics market, by country, 2014 - 2026 (USD Million)
Table 79 Latin America spine biologics market, by product, 2014 - 2026 (USD Million)
Table 80 Latin America spine allografts market by type, 2014 - 2026 (USD Million)
Table 81 Latin America bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 82 Latin America spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 83 Brazil spine biologics market, by product, 2014 - 2026 (USD Million)
Table 84 Brazil spine allografts market by type, 2014 - 2026 (USD Million)
Table 85 Brazil bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 86 Brazil spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 87 Mexico spine biologics market, by product, 2014 - 2026 (USD Million)
Table 88 Mexico spine allografts market by type, 2014 - 2026 (USD Million)
Table 89 Mexico bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 90 Mexico spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 91 Argentina spine biologics market, by product, 2014 - 2026 (USD Million)
Table 92 Argentina spine allografts market by type, 2014 - 2026 (USD Million)
Table 93 Argentina bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 94 Argentina spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 95 MEA spine biologics market, by country, 2014 - 2026 (USD Million)
Table 96 MEA spine biologics market, by product, 2014 - 2026 (USD Million)
Table 97 MEA spine allografts market by type, 2014 - 2026 (USD Million)
Table 98 MEA bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 99 MEA spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 100 South Africa spine biologics market, by product, 2014 - 2026 (USD Million)
Table 101 South Africa spine allografts market by type, 2014 - 2026 (USD Million)
Table 102 South Africa bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 103 South Africa spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 104 Saudi Arabia spine biologics market, by product, 2014 - 2026 (USD Million)
Table 105 Saudi Arabia spine allografts market by type, 2014 - 2026 (USD Million)
Table 106 Saudi Arabia bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 107 Saudi Arabia spine biologics market, by end-use, 2014 - 2026 (USD Million)
Table 108 UAE spine biologics market, by product, 2014 - 2026 (USD Million)
Table 109 UAE spine allografts market by type, 2014 - 2026 (USD Million)
Table 110 UAE bone graft substitutes market by type, 2014 - 2026 (USD Million)
Table 111 UAE spine biologics market, by end-use, 2014 - 2026 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Spine biologics market: Market snapshot
Fig. 9 Spine biologics market: Market segmentation
Fig. 10 Spine biologics market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Spine biologics market driver impact
Fig. 14 Spine biologics market restraint impact
Fig. 15 Spine biologics market porter's five forces analysis
Fig. 16 Spine biologics market PESTEL analysis
Fig. 17 Spine biologics market segment dashboard
Fig. 18 Spine biologics market: product movement Analysis
Fig. 19 Spinal allografts market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 20 Plasma Rich Plasma (PRP) Spine Biologics market estimates and forecast, 2015 - 2026 (USD Million
Fig. 21 Machined bones allograft market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 22 DBM market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 23 Bone graft substitutes market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 24 BMP market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 25 Synthetic bone grafts market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 26 Cell-based matrix market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 27 Spine Biologics market: Segment dashboard
Fig. 28 Spine Biologics market: Surgery movement analysis
Fig. 29 Spine biologics market: Segment dashboard
Fig. 30 Spine biologics market: End-use movement analysis
Fig. 31 Hospitals market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 32 Ambulatory surgical centers market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 33 Others market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 34 Global spine biologics market: Regional movement analysis
Fig. 35 Global spine biologics market: Regional outlook and key takeaways
Fig. 36 Global market share, by region
Fig. 37 North America market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 38 U.S. market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 39 Canada market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 40 Europe market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 41 U.K. market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 42 Germany market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 43 France market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 44 Italy market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 45 Spain market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 46 Russia market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 47 Asia Pacific market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 48 China market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 49 Japan market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 50 India market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 51 Australia market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 52 Singapore market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 53 South Korea market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 54 Latin America market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 55 Brazil market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 56 Mexico market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 57 Argentina market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 58 Middle East and Africa market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 59 South Africa market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 60 Saudi Arabia market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 61 UAE market estimates and forecast, 2014 - 2026 (USD Million)